IGF2BP2 and familial pancreatic carcinoma: To investigate the clinical importance of IGF2BP2 in pancreatic cancer, we first determined IGF2BP2 expression by immunohistochemistry (IHC) staining in the pancreatic cancer tissue microarray (TMA) slide containing 82 pancreatic cancer and 54 normal samples (Supplementary Table 2).